Orthofix Medical Inc. financial data

Symbol
OFIX on Nasdaq
Location
3451 Plano Parkway, Lewisville, TX
Fiscal year end
December 23
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260 % +3.46%
Quick Ratio 114 % -15.3%
Debt-to-equity 81.8 % +36.8%
Return On Equity -25.6 % -20.4%
Return On Assets -14.1 % -5.87%
Operating Margin -11.4 % +2.06%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.6M shares +3.63%
Common Stock, Shares, Outstanding 39.5M shares +3.43%
Entity Public Float 504M USD -24%
Common Stock, Value, Issued 3.95M USD +3.43%
Weighted Average Number of Shares Outstanding, Basic 39.8M shares +3.32%
Weighted Average Number of Shares Outstanding, Diluted 39.8M shares +3.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 818M USD +4.31%
Research and Development Expense 69.3M USD -6.09%
Selling and Marketing Expense 395M USD +13.6%
General and Administrative Expense 134M USD -1.37%
Operating Income (Loss) -93.4M USD -2.12%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -118M USD -1.82%
Income Tax Expense (Benefit) 788K USD -72%
Net Income (Loss) Attributable to Parent -119M USD -0.08%
Earnings Per Share, Basic -3 USD/shares +2.25%
Earnings Per Share, Diluted -3 USD/shares +2.25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.9M USD +109%
Accounts Receivable, after Allowance for Credit Loss, Current 131M USD +4.78%
Inventory, Net 174M USD -15.4%
Assets, Current 394M USD +2.06%
Deferred Income Tax Assets, Net 1.54M USD -25.9%
Property, Plant and Equipment, Net 130M USD -11.4%
Operating Lease, Right-of-Use Asset 24M USD +32.7%
Intangible Assets, Net (Excluding Goodwill) 75.6M USD -27.6%
Goodwill 195M USD 0%
Other Assets, Noncurrent 37.8M USD +6.64%
Assets 833M USD -4.06%
Accounts Payable, Current 50.5M USD +7.22%
Employee-related Liabilities, Current 43.9M USD +13.1%
Accrued Liabilities, Current 11.4M USD -6.55%
Liabilities, Current 160M USD -1.27%
Deferred Income Tax Liabilities, Net 5.64M USD +35.2%
Operating Lease, Liability, Noncurrent 26.1M USD +73.6%
Other Liabilities, Noncurrent 55.8M USD +12.1%
Liabilities 390M USD +14.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 634K USD
Retained Earnings (Accumulated Deficit) -366M USD -48.2%
Stockholders' Equity Attributable to Parent 442M USD -15.9%
Liabilities and Equity 833M USD -4.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.4M USD +1.1%
Net Cash Provided by (Used in) Financing Activities -651K USD -103%
Net Cash Provided by (Used in) Investing Activities -6.74M USD +38%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 39.5M shares +3.43%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.3M USD -205%
Deferred Tax Assets, Valuation Allowance 229M USD +14.3%
Deferred Tax Assets, Gross 239M USD +11.8%
Operating Lease, Liability 18.1M USD -12.1%
Payments to Acquire Property, Plant, and Equipment 10.5M USD -8.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -118M USD +0.41%
Lessee, Operating Lease, Liability, to be Paid 22.4M USD -14.5%
Property, Plant and Equipment, Gross 352M USD +1.25%
Operating Lease, Liability, Current 3.16M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.01M USD +4.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.19M USD +6.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 445K USD +9.07%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.33M USD -23.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.65M USD -20.8%
Unrecognized Tax Benefits 1.7M USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.84M USD -46.5%
Operating Lease, Payments 2.37M USD +9.67%
Depreciation, Depletion and Amortization 80.2M USD +38.3%
Deferred Tax Assets, Net of Valuation Allowance 10.7M USD -23.7%
Share-based Payment Arrangement, Expense 28.6M USD +0.64%